Search

Your search keyword '"M. Mainke"' showing total 13 results
Start Over Author "M. Mainke"
13 results on '"M. Mainke"'

1. Formation of cytosine arabinoside-5′-triphosphate in different cultured lymphoblastic leukaemic cells with reference to their drug sensitivity

Author

U. Köhl, D. Schwabe, E. Montag, S. Bauer, B. Mieth, J. Cinatl, E. Rohrbach, M. Mainke, A. Weiβflog, C. Sommerschuh, and B. Kornhuber

Subjects
Drug, Cancer Research, Time Factors, media_common.quotation_subject, Biology, High-performance liquid chromatography, chemistry.chemical_compound, Arabinofuranosylcytosine Triphosphate, Tumor Cells, Cultured, medicine, Humans, heterocyclic compounds, MTT assay, Child, media_common, Dose-Response Relationship, Drug, Cytarabine, food and beverages, biochemical phenomena, metabolism, and nutrition, Leukemia, Lymphoid, carbohydrates (lipids), Oncology, chemistry, Biochemistry, Cell culture, lipids (amino acids, peptides, and proteins), Arabinofuranosylcytosine triphosphate, Cytosine, Intracellular, medicine.drug
Abstract

The accumulation of intracellular cytosine arabinoside-5'-triphosphate (Ara-CTP) is determined in five lymphoblastic cell lines: Molt 4, H9 and three newly established cell lines from paediatric patients, KFB-1, KFB-2, KFT-1. The cell lines KFB-1 and KFB-2 are B-lymphoblastic (B-ALL), the others are T-lymphoblastic leukaemic cells (T-ALL). The Ara-CTP levels were compared with the sensitivity of the cells to Ara-C. The cells were incubated at different concentrations (100 nM-100 microM) of Ara-C for 4 h or incubated for variable times (30 min-11 h) at 0.1, 1 and 10 microM Ara-C to form Ara-CTP. The Ara-CTP-concentrations were measured by high pressure liquid chromatography (HPLC). To determine the sensitivity of the cells to Ara-C, the MTT colorimetric-assay was used. The studies indicate that different B- and T-lymphoblastic leukaemia cell lines accumulate Ara-CTP to a markedly different extent. Ara-CTP plateau levels and sensitivity of the cells to Ara-C correlated well in four of the five cells lines studied.

Published
1995

2. Aphidicolin selectively kills neuroblastoma cells in vitro

Author

Holger F. Rabenau, Jindrich Cinatl, Albrecht Weißflog, M. Mainke, Hans-Wilhelm Doerr, Jaroslav Cinatl, Gabriele Steigmann, and Bernhard Kornhuber

Subjects
Aphidicolin, Cancer Research, Programmed cell death, animal structures, Cell Survival, viruses, Antineoplastic Agents, Cell Line, HeLa, Neuroblastoma, chemistry.chemical_compound, Tumor Cells, Cultured, medicine, Humans, Viability assay, biology, urogenital system, organic chemicals, DNA, biochemical phenomena, metabolism, and nutrition, Embryo, Mammalian, biology.organism_classification, medicine.disease, Molecular biology, In vitro, Cell killing, Oncology, chemistry, Cell culture, Immunology, Drug Screening Assays, Antitumor, Cell Division
Abstract

Aphidicolin is a tetracyclic diterpene antibiotic which is known to inhibit the growth of eucaryotic cells by reversible binding to DNA polymerase α without significant effect on cell viability in most common human cell lines. We observed that aphidicolin at a concentration of 5 × 10 −7 M kills all cells of four human neuroblastoma cell lines. In contrast, viability of normal human embryonal cells and of human continuous cell lines including HeLa, H9, A549 and Caco-2 was influenced only moderately by aphidicolin. In addition, neuroblastoma cells were killed after treatment with 5 × 10 −7 M aphidicolin in cocultures with normal embryonal cells which continued to proliferate after removal of aphidicolin. These results show that aphidicolin provides an agent which selectively kills neuroblastoma cells in vitro.

Published
1992

3. Scientific Proceedings Second International Symposium on Cytostatic Drug Resistance

Author

Bridget T. Hill, L. K. Hosking, S. McClean, S. A. Shellard, W. C. M. Dempke, R. D. H. Whelan, M. Sehested, E. Friche, E. J. F. Demant, P. B. Jensen, B. P. Kopnin, B. Wolf, A. Seidel, M. Nickelsen, I. Brandt, G. Heinemann, M. Dietel, S. Bremer, T. Hoof, B. Tümmler, H. J. Broxterman, C. H. M. Versantvoort, C. M. Kuiper, N. Feller, G. J. Schuurhuis, J. Lankelma, S. Gupta, T. Tsuruo, C. Kim, S. Gollapudi, A. Bittl, M. Nap, W. Jäger, B. Lathan, N. Lang, N. T. Raikhlin, A. G. Perevozchikov, J. L. Volodina, T. Licht, H. H. Fiebig, K. J. Bross, F. Herrmann, R. Mertelsmann, I. Bashir, K. Sikora, C. S. Foster, M. Castagna, P. Viacava, M. Cianfrigliao, A. Favati, P. Collecchi, M. A. Caligo, G. Cipollini, G. Bevilacqua, D. Schrenk, T. W. Gant, J. A. Silverman, S. S. Thorgeirsson, A. Harstrick, Z. G. Zhang, H. J. Schmoll, Y. Rustum, M. Mitze, T. Beck, W. Weikel, C. Brumm, P. G. Knapstein, T. McDonald, P. Gardner, N. Kang, S. A. M. van der Heyden, H. J. Elst, U. Stein, B. Jandrig, H. Krause, P. Schmidt-Peter, J. Frege, V. Wunderlich, E. Boven, C. K. van Kalken, H. M. Pinedo, W. Gebauer, E. Fallgren-Gebauer, M. Diete, T. Wagner, M. R. Müller, K. Lennartz, H. R. Nowrousian, S. Seeber, A. A. Shtil, A. R. Kazarov, A. V. Gudkov, A. A. Stavrovskaya, F. H. Djuraeva, T. P. Stromskaya, A. Noller, G. Frese, M. Neumann, A. Wilisch, H. Probst, V. Gekeler, R. Handgretinger, H. Schmidt, C. P. Muller, R. Dopfer, T. Klingebiel, D. Niethammer, S. Weger, H. Diddens, E. Daumiller, A. Bunge, R. Lilischkis, A. Salmassi, M. Kopun, H. Scherthan, C. Granzow, I. Leuschner, D. Schmidt, H. Hoffmann, D. Harms, G. V. Scagliotli, E. Leonardo, S. Cappia, G. Esposito, M. Tombesi, M. Cianfriglia, G. V. Esposito, N. Merendino, M. Viora, M. Caserta, E. Tritarelli, E. Rocca, G. Boccoli, P. Samoggia, C. Fossati, U. Testa, C. Peschle, J. L. Darling, S. M. Ashmore, D. C. Peterson, D. G. T. Thomas, R. A. Kramer, R. Stanlunas, T. Summerhayes, T. Lion, R. H. Shoemaker, L. Wu, A. Smythe, M. R. Boyd, W. T. Beck, M. K. Danks, J. S. Wolverton, M. Chen, B. Y. Bugg, D. P. Suttle, C. V. Catapano, D. J. Fernandes, F. Gieseler, F. Boege, R. Erttmann, H. Arps, L. Zwelling, K. Wilms, H. Biersack, G. J. L. Kaspers, R. Pieters, E. Klumper, F. C. de Waal, E. R. van Wering, A. J. P. Veerman, C. A. Schmidt, F. Lorenz, A. Schäfer, A. Kirsch, W. Siegert, D. Huhn, W. E. Simon, G. Siebert, M. Schneider, M. Oettling, A. Reymann, R. Entmann, S. Schmidt, C. Woermann, C. Windmeier, I. Herzig, B. Schaefer, H. J. Heidebrecht, H. H. Wacker, H. Künnemann, Th. H. M. van Heijningen, M. L. Slovak, J. P. A. Baak, K. Steidtmann, A. -M. J. Fichtinger-Schepman, B. I. Hill, K. J. Scanlon, W. J. Zeller, G. Chen, J. A. Gietema, E. G. E de Vries, D.Th Sleijfer, P. H. B. Willemse, H. J. Guchelaar, D. R. A. Uges, P. Aulenbacher, R. Voegeli, N. H. Mulder, C. Skrezek, H. Bertermann, H. Eichholtz-Wirth, R. Born, H. Bier, M. Koch, G. Bernhardt, K. Hählen, H. Reile, C. H. van Zantwijk, T. Görögh, B. Lippert, J. A. Werner, J. E. Eickbohm, G. H. Mickiseh, M. M. Gottesman, I. Pastan, J. Hofmann, A. Wolf, M. Spitaler, G. Bock, H. Grunicke, H. Ponstingl, I. Roth, C. Dörner, G. Looft, G. J. Ossenkoppele, G. L. Scheffer, G. Atassi, A. Pierre, L. Kraus, S. Leonce, G. Regnier, A. Dhainaut, M. Stöhr, C. Rohlff, R. I. Glazer, Y. S. Cho-Chung, V. Höllt, M. Kouba, G. Vogt, H. Allmeier, N. I. Nissen, S. Cros, N. Guilbaud, T. Dunn, M. Berlion, J. P. Bizzari, A. M. Messing, A. Matuschek, I. Mutter, J. C. W. Kiwit, L. Bastian, P. E. Goretzki, A. Frilling, D. Simon, H. D. Röher, A. Reichle, F. Altmayr, J. Rastetter, C. Erbil, G. Jaques, M. Maasberg, K. Havemann, K. Häußermann, H. -J. Heidebrecht, W. Van de Vrie, E. E. O. Gheuens, N. M. C. Durante, E. A. De Bruijn, R. L. Marquet, A. T. Van Oosterom, A. M. M. Eggermont, M. W. Stow, S. E. Vickers, J. R. Warr, E. Roller, M. Eichelbaum, B. Klumpp, J. Krause, K. Schumacher, S. Hörner, A. Laßmann, U. Traugott, E. Schlick, D. Bürkle, BW Futscher, AF List, WS Dalton, E. Ladda, K. Bühl, A. Weimer, C. Eser, K. Hamprecht, K. P. Schalk, C. Jackisch, B. Brandt, M. Blum, F. Louwen, K. Schulz, J. P. Hanker, U. Rüther, A. Schmidt, H. A. G. Müller, C. Nunnensiek, H. Bader, F. Eisenberger, P. Jipp, B. Niethammer, C. Muller, V. Ling, F. Joncourt, S. Redmond, K. Buser, M. Fey, A. Tobler, K. Brunner, A. Gratwohl, T. Cerrry, V. Nuessler, R. Pelka-Fleischer, C. Nerl, B. Beckert, W. Wilmanns, S. Hegewisch-Becker, M. Fliegner, A. Zander, D. K. Hossfeld, J. Blanz, K. Mewes, G. Ehninger, K. -P. Zeller, H. Schuldes, G. Herrmann, W. Boeckmann, R. Schroeder, D. Jonas, K. -H. Zurborn, H. D. Bruhn, L. Uharek, B. Glass, W. Gassmann, H. Loeffler, W. Mueller-Ruohholtz, W. Mueller-Ruchholtz, K. Jaquet, H. Kreipe, J. Felgner, H. J. Radzun, M. R. Parwaresch, EA Kogan, NN Mazurenko, SM Sekamova, H. Wolf, K. Röhe, K. Wilkens, M. Clausen, E. Henze, J. van der Bosch, S. Rüller, M. Schlaak, U. Köhl, D. Schwabe, E. Rohrbach, E. Montag, S. Bauer, J. Cinatl, I. Cinatl, M. Mainke, H. Geiss, B. Kornhuber, H. Juhl, H. Stritzel, H. Kalhoff, W. Schniegel, T. Menke, B. Pröbsting, P. Schulze-Westhoff, J. Boos, J. Weidner, N. Wedemeyer, K. Wiedorn, Y. Ueda, S. Blasius, P. Wuisman, W. Böcker, A. Roessner, B. Dockhorn-Dworniczak, D. Ramm, J. Knebel, W. Sass, M. Aufderheide, and J. Seifert

Subjects
Cancer Research, medicine.medical_specialty, Oncology, business.industry, medicine, General Medicine, Drug resistance, Pharmacology, Intensive care medicine, business
Published
1991

4. 2′,3′-Dideoxycytidine Preferentially Inhibits in vitro Growth of Granulocyte-Macrophage Colony-Forming Cells from Patients with Chronic Myeloid Leukemia

Author

J. Cinatl Jr., J. Cinatl, E.S. Gussetis, U. Nemeth, M. Mainke, B. Kornhuber, M. Brendel, and H.W. Doerr

Subjects
Granulocyte, Biology, Zalcitabine, chemistry.chemical_compound, Bone Marrow, 2'3' dideoxycytidine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Drug Discovery, medicine, Humans, Pharmacology (medical), Pharmacology, Deoxyadenosines, Nucleoside analogue, Granulocyte-Macrophage Colony-Stimulating Factor, Myeloid leukemia, General Medicine, Deoxyuridine, Virology, Molecular biology, Infectious Diseases, medicine.anatomical_structure, Granulocyte macrophage colony-stimulating factor, Oncology, chemistry, Neoplastic Stem Cells, Bone marrow, medicine.drug
Abstract

The effect of three nucleoside analogs, including 2-methyl-2'-deoxyadenosine (MDA), 5-amino-2'-deoxyuridine (ADU) and 2',3'-dideoxycytidine (DDC) on colony formation from unfractionated human bone marrow obtained from volunteers expressing parameters typical for normal cells (NBM) and from patients with the diagnosis of chronic myeloid leukemia (CMLBM) was observed. For the clonal growth of granulocyte-macrophage colony-forming cells (GM-CFC), a semisolid fibrin clot culture medium supplemented with 20% fetal bovine serum and 10% human placental conditioned medium was used. DDC has been shown to be at least a 10-fold more potent inhibitor for the growth of GM-CFC from CMLBM than from NBM. On the other hand, the effect of MDA and ADU on CMLBM did not differ markedly from the effect on NBM. These results suggest that DDC inhibits preferentially progenitor cells from CMLBM.

Published
1991

5. Decreased anti-human immunodeficiency virus type-1 activities of 2',3'-dideoxynucleoside analogs in MOLT-4 cell sublines resistant to 2',3'-dideoxynucleoside analogs

Author

J, Cinatl, B, Weber, H, Rabenau, A, Weissflog, M, Mainke, B, Kornhuber, and H W, Doerr

Subjects
Didanosine, Microscopy, Electron, Time Factors, Zalcitabine, HIV Core Protein p24, HIV-1, Humans, Drug Resistance, Microbial, HIV Infections, Zidovudine, Dideoxynucleosides, Cell Line, Culture Media
Abstract

Human T-lymphoid MOLT-4 cells were grown continuously for more than 1 year in medium containing either 3'-azido-2',3'-dideoxythymidine (AZT), 2',3'-dideoxyinosine (ddI) or 2',3'-dideoxycytidine (ddC) at concentrations similar to peak plasma levels found in clinical trials in patients with AIDS. To test antiviral activities of the nucleoside analogs against HIV-1 in the cell sublines designated MOLT-4r-AZT, MOLT-4r-ddI and MOLT-4r-ddC, the number of infected cells, p24 HIV-1 antigen in culture medium and syncytium formation of infected cultures were determined. The results showed that anti-HIV-1 activities of AZT, ddI and ddC were significantly decreased in the resistant MOLT-4 cell sublines grown continuously with the respective nucleoside analog, probably due to the development of cell populations resistant to the drugs.

Published
1993

6. In vitro differentiation of human neuroblastoma cells induced by sodium phenylacetate

Author

Albrecht Weißflog, Hans-Wilhelm Doerr, M. Mainke, Bernhard Kornhuber, Jindrich Cinatl, Jaroslav Cinatl, and Holger F. Rabenau

Subjects
Cancer Research, Cell Survival, Cellular differentiation, Tretinoin, Biology, Proto-Oncogene Proteins c-myc, Neuroblastoma, medicine, Tumor Cells, Cultured, Humans, Viability assay, Phenylacetates, DNA synthesis, Cell growth, Cell Differentiation, DNA, Neoplasm, medicine.disease, Molecular biology, In vitro, Culture Media, Phenylacetate, Oncology, Biochemistry, Cell culture, Cell Division
Abstract

Sodium phenylacetate (NaPA) at concentrations ranging from 2 to 6 mM stimulated morphological differentiation of two human neuroblastoma cell lines IMR-32 and UKF-NB-3. These concentrations inhibited growth and DNA synthesis of the cells in a dose dependent manner without significant effect on cell viability. The differentiated cells showed pseudoganglia formation and extension of cellular processes. The morphological differentiation in both cell lines was accompanied by decreased expression of N-myc oncoprotein. These results suggest that NaPA at concentrations, which have been achieved in humans with no significant adverse effects, promotes differentiation of cultured human neuroblastoma cells in association with the reduced expression of the malignant phenotype.

Published
1993

7. Effect of aciclovir on the replication of herpes simplex virus type 1 in MA-104 cell line resistant to aciclovir

Author

J, Cinatl, H, Rabenau, M, Mainke, B, Kornhuber, and H W, Doerr

Subjects
Acyclovir, Animals, Simplexvirus, Drug Resistance, Microbial, Haplorhini, Virus Replication, Cell Line
Abstract

A culture of monkey kidney cells (MA-104) resistant to aciclovir (CAS 59277-89-3) was established. The resistant cells were continuously grown in medium containing 200 mumol/l aciclovir whereas normal cells died in such medium. The doses of aciclovir required for 50 and 90% reduction in virus yield were for several Herpes simplex virus Type 1 clinical isolates up to 5-fold higher in resistant than in normal MA-104 cells; in contrast, doses required for 99% reduction in virus yield could be as much as 50-fold higher in the resistant cells. Virus yields developed in the presence of 30 mumol aciclovir in culture medium were at least 10(3)-fold higher in resistant than in normal MA-104 cells. The results showed that the antiviral effect of aciclovir may be significantly decreased in the cell line which developed resistance to aciclovir.

Published
1992

8. Formation of cytosine arabinoside-5'-triphosphate in different cultured lymphoblastic leukaemic cells with reference to their drug sensitivity.

Author

Köhl U, Schwabe D, Montag E, Bauer S, Mieth B, Cinatl J, Cinatl J Jr, Rohrbach E, Mainke M, and Weissflog A

Subjects
Child, Cytarabine pharmacology, Dose-Response Relationship, Drug, Humans, Time Factors, Tumor Cells, Cultured drug effects, Tumor Cells, Cultured metabolism, Arabinofuranosylcytosine Triphosphate metabolism, Leukemia, Lymphoid metabolism
Abstract

The accumulation of intracellular cytosine arabinoside-5'-triphosphate (Ara-CTP) is determined in five lymphoblastic cell lines: Molt 4, H9 and three newly established cell lines from paediatric patients, KFB-1, KFB-2, KFT-1. The cell lines KFB-1 and KFB-2 are B-lymphoblastic (B-ALL), the others are T-lymphoblastic leukaemic cells (T-ALL). The Ara-CTP levels were compared with the sensitivity of the cells to Ara-C. The cells were incubated at different concentrations (100 nM-100 microM) of Ara-C for 4 h or incubated for variable times (30 min-11 h) at 0.1, 1 and 10 microM Ara-C to form Ara-CTP. The Ara-CTP-concentrations were measured by high pressure liquid chromatography (HPLC). To determine the sensitivity of the cells to Ara-C, the MTT colorimetric-assay was used. The studies indicate that different B- and T-lymphoblastic leukaemia cell lines accumulate Ara-CTP to a markedly different extent. Ara-CTP plateau levels and sensitivity of the cells to Ara-C correlated well in four of the five cells lines studied.

Published
1995
Full Text
View/download PDF

9. Decreased anti-human immunodeficiency virus type-1 activities of 2',3'-dideoxynucleoside analogs in MOLT-4 cell sublines resistant to 2',3'-dideoxynucleoside analogs.

Author

Cinatl J Jr, Cinatl J, Weber B, Rabenau H, Weissflog A, Mainke M, Kornhuber B, and Doerr HW

Subjects
Cell Line, Culture Media, Didanosine pharmacology, Drug Resistance, Microbial, HIV Core Protein p24 analysis, HIV Infections drug therapy, HIV Infections microbiology, HIV-1 isolation & purification, HIV-1 ultrastructure, Humans, Microscopy, Electron, Time Factors, Zalcitabine pharmacology, Zidovudine pharmacology, Dideoxynucleosides pharmacology, HIV-1 drug effects
Abstract

Human T-lymphoid MOLT-4 cells were grown continuously for more than 1 year in medium containing either 3'-azido-2',3'-dideoxythymidine (AZT), 2',3'-dideoxyinosine (ddI) or 2',3'-dideoxycytidine (ddC) at concentrations similar to peak plasma levels found in clinical trials in patients with AIDS. To test antiviral activities of the nucleoside analogs against HIV-1 in the cell sublines designated MOLT-4r-AZT, MOLT-4r-ddI and MOLT-4r-ddC, the number of infected cells, p24 HIV-1 antigen in culture medium and syncytium formation of infected cultures were determined. The results showed that anti-HIV-1 activities of AZT, ddI and ddC were significantly decreased in the resistant MOLT-4 cell sublines grown continuously with the respective nucleoside analog, probably due to the development of cell populations resistant to the drugs.

Published
1993

10. In vitro differentiation of human neuroblastoma cells induced by sodium phenylacetate.

Author

Cinatl J, Cinatl J, Mainke M, Weissflog A, Rabenau H, Kornhuber B, and Doerr HW

Subjects
Cell Division drug effects, Cell Survival drug effects, Culture Media chemistry, DNA, Neoplasm biosynthesis, DNA, Neoplasm drug effects, Humans, Neuroblastoma metabolism, Proto-Oncogene Proteins c-myc metabolism, Tretinoin pharmacology, Tumor Cells, Cultured, Cell Differentiation drug effects, Neuroblastoma pathology, Phenylacetates pharmacology
Abstract

Sodium phenylacetate (NaPA) at concentrations ranging from 2 to 6 mM stimulated morphological differentiation of two human neuroblastoma cell lines IMR-32 and UKF-NB-3. These concentrations inhibited growth and DNA synthesis of the cells in a dose dependent manner without significant effect on cell viability. The differentiated cells showed pseudoganglia formation and extension of cellular processes. The morphological differentiation in both cell lines was accompanied by decreased expression of N-myc oncoprotein. These results suggest that NaPA at concentrations, which have been achieved in humans with no significant adverse effects, promotes differentiation of cultured human neuroblastoma cells in association with the reduced expression of the malignant phenotype.

Published
1993
Full Text
View/download PDF

11. Aphidicolin selectively kills neuroblastoma cells in vitro.

Author

Cinatl J, Cinatl J, Mainke M, Weissflog A, Steigmann G, Rabenau H, Doerr HW, and Kornhuber B

Subjects
Cell Division drug effects, Cell Line, Cell Survival drug effects, DNA drug effects, Drug Screening Assays, Antitumor, Embryo, Mammalian cytology, Humans, Neuroblastoma pathology, Tumor Cells, Cultured, Antineoplastic Agents pharmacology, Aphidicolin pharmacology, Neuroblastoma drug therapy
Abstract

Aphidicolin is a tetracyclic diterpene antibiotic which is known to inhibit the growth of eucaryotic cells by reversible binding to DNA polymerase alpha without significant effect on cell viability in most common human cell lines. We observed that aphidicolin at a concentration of 5 x 10(-7) M kills all cells of four human neuroblastoma cell lines. In contrast, viability of normal human embryonal cells and of human continuous cell lines including HeLa, H9, A549 and Caco-2 was influenced only moderately by aphidicolin. In addition, neuroblastoma cells were killed after treatment with 5 x 10(-7) M aphidicolin in cocultures with normal embryonal cells which continued to proliferate after removal of aphidicolin. These results show that aphidicolin provides an agent which selectively kills neuroblastoma cells in vitro.

Published
1992
Full Text
View/download PDF

12. Effect of aciclovir on the replication of herpes simplex virus type 1 in MA-104 cell line resistant to aciclovir.

Author

Cinatl J Jr, Cinatl J, Rabenau H, Mainke M, Kornhuber B, and Doerr HW

Subjects
Animals, Cell Line, Drug Resistance, Microbial, Haplorhini, Virus Replication drug effects, Acyclovir pharmacology, Simplexvirus drug effects
Abstract

A culture of monkey kidney cells (MA-104) resistant to aciclovir (CAS 59277-89-3) was established. The resistant cells were continuously grown in medium containing 200 mumol/l aciclovir whereas normal cells died in such medium. The doses of aciclovir required for 50 and 90% reduction in virus yield were for several Herpes simplex virus Type 1 clinical isolates up to 5-fold higher in resistant than in normal MA-104 cells; in contrast, doses required for 99% reduction in virus yield could be as much as 50-fold higher in the resistant cells. Virus yields developed in the presence of 30 mumol aciclovir in culture medium were at least 10(3)-fold higher in resistant than in normal MA-104 cells. The results showed that the antiviral effect of aciclovir may be significantly decreased in the cell line which developed resistance to aciclovir.

Published
1992

13. 2',3'-Dideoxycytidine preferentially inhibits in vitro growth of granulocyte-macrophage colony-forming cells from patients with chronic myeloid leukemia.

Author

Cinatl J Jr, Cinatl J, Gussetis ES, Nemeth U, Mainke M, Kornhuber B, Brendel M, and Doerr HW

Subjects
Bone Marrow growth & development, Bone Marrow pathology, Deoxyadenosines pharmacology, Deoxyuridine pharmacology, Humans, Neoplastic Stem Cells drug effects, Bone Marrow drug effects, Granulocyte-Macrophage Colony-Stimulating Factor antagonists & inhibitors, Leukemia, Myelogenous, Chronic, BCR-ABL Positive pathology, Zalcitabine pharmacology
Abstract

The effect of three nucleoside analogs, including 2-methyl-2'-deoxyadenosine (MDA), 5-amino-2'-deoxyuridine (ADU) and 2',3'-dideoxycytidine (DDC) on colony formation from unfractionated human bone marrow obtained from volunteers expressing parameters typical for normal cells (NBM) and from patients with the diagnosis of chronic myeloid leukemia (CMLBM) was observed. For the clonal growth of granulocyte-macrophage colony-forming cells (GM-CFC), a semisolid fibrin clot culture medium supplemented with 20% fetal bovine serum and 10% human placental conditioned medium was used. DDC has been shown to be at least a 10-fold more potent inhibitor for the growth of GM-CFC from CMLBM than from NBM. On the other hand, the effect of MDA and ADU on CMLBM did not differ markedly from the effect on NBM. These results suggest that DDC inhibits preferentially progenitor cells from CMLBM.

Published
1991
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results